greeksoup/ stock research

Cigna Group (CI) FY2024 results: revenue $247.1 billion, up 26.6% on the year

Cigna Group (CI) reported revenue of $247.1 billion for fiscal 2024, the year ended 31 December 2024, up 26.6% on the year before. Net income was $3.4 billion, down 33.5%, and diluted earnings per share $12.12. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2025.

Revenue
$247.1 billion
+26.6% on the year
FY2017FY2024
Operating margin
3.8%
4.4% a year earlier
FY2017FY2024
Net income
$3.4 billion
-33.5% on the year
FY2017FY2024
Diluted EPS
$12.12
-30.3% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue247,121195,265180,516+26.6%
Cost of revenue182,509133,801124,834+36.4%
Gross profit64,61261,46455,682+5.1%
Gross margin26.1%31.5%30.8%
Selling, general and administrative14,84414,82213,186+0.1%
Operating income9,4178,5368,450+10.3%
Operating margin3.8%4.4%4.7%
Interest expense1,5001,4001,300+7.1%
Pre-tax income5,2695,5138,397-4.4%
Income tax1,4911411,615+957.4%
Effective tax rate28.3%2.6%19.2%
Net income3,4345,1646,704-33.5%
Net margin1.4%2.6%3.7%
Diluted EPS$12.12$17.39$21.41-30.3%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow10,36311,8138,656-12.3%
Cash from investing-2,102-5,1743,098
Cash from financing-7,647-4,294-11,240
Depreciation and amortisation2,7753,0352,937-8.6%
Share-based compensation308286264+7.7%
Buybacks7,0342,2847,607+208.0%
Dividends paid1,5671,4501,384+8.1%
Dividend per share$5.60$4.92$4.48+13.8%
Diluted shares, weighted283m297m313m-4.6%
Shares outstanding at period end274m293m299m-6.4%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity41,03346,22344,675-11.2%
Non-controlling interest21021.013.0+900.0%
Redeemable equity0.010766.0
Debt31,97230,93031,093+3.4%
Operating lease liabilitiesn/a340346
Finance lease liabilities41.066.066.0-37.9%
Other liabilities82,62575,07467,673+10.1%
Total liabilities and equity155,881152,761143,932+2.0%
Fixed assetsn/an/a3,774
Goodwill44,37044,25945,811+0.3%
Intangible assets29,41730,86332,492-4.7%
Investments15,79318,91017,193-16.5%
Cash and equivalents7,5507,8225,924-3.5%
Receivables24,22717,72217,218+36.7%
Inventory6,6925,6454,777+18.5%
Other assets27,83227,54016,743+1.1%
Total assets155,881152,761143,932+2.0%

10-K for the year ended 31 December 2024, filed 27 February 2025: the filing.